NTRB

Nutriband Inc. Common Stock

5.55

USD

-0.03

-0.45%

Nov 06, 15:59 UTC -5

Closed

After-Market

5.55

0.00

+0.09%

Nutriband Inc. Common Stock (NTRB) Earnings

NTRB Earnings Reports

Positive Surprise Ratio

NTRB beat 7 of 18 last estimates.

39%

Next Report

Date of Next Report

Dec 09, 2026

Estimate for Q3 27 (Revenue/ EPS)

Implied change from Q2 27 (Revenue/ EPS)

Implied change from Q3 26 (Revenue/ EPS)

Nutriband Inc. Common Stock earnings per share and revenue

On Sep 07, 2026, NTRB reported earnings of -- USD per share (EPS) for Q2 27, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q3 27, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Cronos Group Inc. Common Share

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.03

Actual

$0.04

Surprise

+17.65%

Aclaris Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.16

Actual

-$0.12

Surprise

+28.49%

Protara Therapeutics, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.35

Surprise

+6.17%

Minerva Neurosciences, Inc

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.12

Actual

$1.94

Surprise

+1,629.97%

Organogenesis Holdings Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.17

Actual

-$0.25

Surprise

-40.06%

ZOETIS INC.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.52

Actual

$1.75

Surprise

+14.64%

Dyne Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.92

Actual

-$1.06

Surprise

-15.57%

Amylyx Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.38

Actual

-$0.38

Surprise

+1.04%

Aldeyra Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.09

Actual

-$0.06

Surprise

+37.43%

Lipocine Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.36

Actual

-$0.08

Surprise

+77.91%

FAQ

What were Nutriband Inc. Common Stock's earnings and revenue for the latest quarter Q2 2027?

For Q2 2027, Nutriband Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Nutriband Inc. Common Stock's Q2 2027 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Nutriband Inc. Common Stock expected to report next?

The next earning report is scheduled for Dec 09, 2026.

What are the forecasts for Nutriband Inc. Common Stock's next earnings report?

Based on -- analysts, Nutriband Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q3 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.